Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor

Cancer Research

Volumn 63, Issue 16, 2003, Pages 5105-5113

  Ramesh, Rajagopal ^a   Mhashilkar, Abner M ^b   Tanaka, Fumihiro ^a   Saito, Yuji ^a   Branch, Cynthia D ^a   Sieger, Kerry ^b   Mumm, John B ^a   Stewart, Alexis L ^b   Boquio, Amelia ^a   Dumoutier, Laure ^c   Grimm, Elizabeth A ^a   Renauld, Jean Christophe ^c   Kotenko, Sergei ^d   Chada, Sunil ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Introgen Therapeutics Inc   (United States)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; ENDOSTATIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEMOGLOBIN; INTERLEUKIN 22; INTERLEUKIN 22 RECEPTOR; INTERLEUKIN 24; INTERLEUKIN RECEPTOR; MATRIGEL; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; LUNG CANCER; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL MOVEMENT; CHEMOKINES, CXC; COLLAGEN; DNA-BINDING PROTEINS; ENDOSTATINS; ENDOTHELIUM, VASCULAR; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; INTERFERON TYPE II; INTERLEUKINS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PEPTIDE FRAGMENTS; RECEPTORS, INTERLEUKIN; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0041513362     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Folkman, J. The role of angiogenesis in tumor growth. Semin. Cancer Biol., 267: 10931-10934, 1992.
2. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat. Med., 1: 21-37, 1995.
3. Fidler, I. J., and Ellis, L. M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79: 185-188, 1994.
4. Klagsburn, M., and D'Amore, P. A. Regulators of angiogenesis. Annu. Rev. Physiol., 53: 217-239, 1991.
5. Bouck, N., Stellmach, V., and Hsu, S. C. How tumors become angiogenic. Adv. Cancer Res., 69: 135-174, 1996.
6. Cristofanilli, M., Charnsangavej, C., and Hortobagyi, G. N. Angiogenesis modulation in cancer research: novel clinical approaches. Nat. Rev., 1: 415-426, 2002.
7. Jiang, H., Lin, J. J., Su, Z. Z., Goldstein, N. I., and Fisher, P. B. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene, 11: 2477-2486, 1995.
8. Rich, B. E., and Kupper, T. S. Cytokines: IL-20: a new effector in skin inflammation. Curr. Biol., 11: 531-534, 2001.
9. Fickenscher, H., Hor, S., Kupers, H., Knappe, A., Wittmann, S., and Sticht, H. The interleukin-10 family of cytokines. Trends Immunol., 23: 89-96, 2002.
10. Jiang, H., Su, Z. Z., Lin, J. J., Goldstein, N. I., Young, C. S., and Fisher, P. B. The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc. Natl. Acad. Sci. USA, 93: 9160-9165, 1996.
11. Su, Z. Z., Madireddi, M. T., Lin, J. J., Young, C. S., Kitada, S., Reed, J. C., Goldstein, N. I., and Fisher, P. B. The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc. Natl. Acad. Sci. USA, 95: 14400-14405, 1998.
12. Saeki, T., Mhashilkar, A., Chada, S., Branch, C., Roth, J. A., and Ramesh, R. Tumor suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer in vitro. Gene Ther., 7: 2051-2057, 2000.
13. Mhashilkar, A. M., Schrock, R. D., Hindi, M., Liao, J., Sieger, K., Kourouma, F., Zou-Yang, X. H., Onishi, E., Takh, O., Vedvick, T. S., Fanger, G., Stewart, L., Watson, G. J., Snary, D., Fisher, P. B., Saeki, T., Roth, J. A., Ramesh, R., and Chada, S. Melanoma-differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy. Mol. Med., 7: 271-282, 2001.
14. Ekmekcioglu, S., Ellerhorst, J., Mhashilkar, A. M., Sahin, A. A., Read, C. M., Prieto, V. G., Chada, S., and Grimm, E. A. Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Int. J. Cancer, 94: 54-59, 2001.
15. Lebedeva, I. V., Su, Z. Z., Chang, Y., Kitada, S., Reed, J. C., and Fisher. P. B. The cancer growth suppressing gene mda-7 induces apoptosis selectively in melanoma cells. Oncogene, 21. 708-718, 2002.
16. Dumoutier, L., Leemans, C., Lejeune, D., Kotenko, S. V., and Renauld, J. C. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol., 167: 3545-3549, 2001.
17. Wang, M., Tan, Z., Zhang, R., Kotenko, S., and Liang, P. Interleukin 24 (mda-7/MOB-5) signals through two heterodimeric receptors IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J. Biol. Chem., 277: 7341-7347, 2002.
18. Caudell, E. G., Mumm, J. B., Poindexter, N., Ekmekcioglu, S., Mhashilkar, A. M., Yang, X. H., Retter, M. W., Hill, P., Chada, S., and Grimm, E. A. The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J. Immunol., 168: 6041-6046, 2002.
19. Ferrantini, M., and Belardelli, F. Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications. Semin. Cancer Biol., 10: 145-157, 2000.
20. Tasaki, K., Yoshida, Y., Maeda, T., Miyauchi, M., Kawamura, K., Takenaga, K., Yamamoto, H., Kouzu, T., Asano, T., Ochiai, T., Sakiyama, S., and Tagawa, M. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type I helper T cells. Cancer Gene Ther., 7: 247-254, 2000.
21. Halin, C., Rondini, S., Nilsson, F., Berndt, A., Kosmehl, H., Zardi, L., and Neri, D. Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature. Nat. Biotechnol., 20: 264-269, 2002.
22. Saeki, T., Mhashilkar, A., Swanson, X., Zou-Yang, H., Zumstein, L., Sieger, K., Branch, C. D., Roth, J. A., Chada, S., and Ramesh, R. Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo. Oncogene, 21: 4558-4566, 2002.
23. Majumder, S., Zhou, L. Z., Chaturvedi, P., Babcock, G., Aras, S., and Ransohoff, R. M. p48/STAT-1α-containing complexes play a predominant role in induction of IFN-γ-inducible protein, 10 kDa (IP-10) by IFN-γ alone or in synergy with TNF-α. J. Immunol., 161: 4736-4744, 1998.
24. Fathallah-Shaykh, H. M., Zhao, L. J., Kafrouni, A. I., Smith, G. M., and Forman, J. Gene transfer of IFN-γ into established brain tumors represses growth by antiangiogenesis. J. Immunol., 164: 217-722, 2000.
25. Angiolillo, A. L., Sgadari, C., and Tosato, G. A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12. Ann. N. Y. Acad. Sci., 795: 158-167, 1996.
26. Pataer, A., Vorburger, S. A., Barber, G. N., Chada, S., Mhashilkar, A. M., Zou-Yang, H., Stewart, A. L., Balachandran, S., Roth, J. A., Hunt, K. K., and Swisher, S. G. Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res., 62: 2239-2243, 2002.
27. Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S., and Martin, G. R. A simple, quantitative method for assessing angiogenesis and anti-angiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Investig., 67: 519-528, 1992.
28. Yamaguchi, N., Anand-Apte, B., Lee, M., Sasaki, T., Fukai, N., Shapiro, R., Que, I., Lowik, C., Timpl, R., and Olsen, B. R. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J., 18: 4414-4423, 1999.
29. Zhang, M., Volpert, O., Shi, Y. H., and Bouck, N. Maspin is an angiogenesis inhibitor. Nat. Med., 6: 196-199, 2000.
30. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell: 88: 277-285, 1997.
31. Deckers, M., van der Pluijm, G., Dooijewaard, S., Kroon, M., van Hinsbergh, V., Papapoulos, S., and Lowik, C. Effect of angiogenic and antiangiogenic compounds on the outgrowth of capillary structures from fetal mouse bone explants. Lab. Investig., 81: 5-15, 2001.
32. Huang, S., Ullrich, S. E., and Bar-Eli, M. Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. J. Interferon Cytokine Res., 19: 697-703, 1999.
33. Maheshwari, R. K., Srikantan, V., Bhartiya, D., Kleinman, H. K., and Grant, D. S. Differential effects of interferon γ and α on in vitro model of angiogenesis. J. Cell. Physiol., 146: 164-169, 1991.
34. Asselin-Paturel, C., Lassau, N., Guinebretiere, J. M., Zhang, J., Gay, F., Bex, F., Hallez, S., Leclere, J., Peronneau, P., Mami-Chouaib, F., and Chouaib, S. Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography. Gene Ther., 6: 606-615, 1999.
35. Qin, Z., and Blankenstein, T. CD4+ T-cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN-γ receptor expression by nonhematopoietic cells. Immunity, 12: 677-686, 2000.
36. Jimenez, B., Volpert, O. V., Crawford, S. E., Febbraio, M., Silverstein, R. L., and Bouck, N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med., 6: 41-48, 2000.
37. Karumanchi, S. A., Jha, V., Ramchandran, R., Karihaloo, A., Tsiokas, L., Chan, B., Dhanabal, M., Hanai, J. I., Venkataraman, G., Shriver, Z., Keiser, N., Kalluri, R., Zeng, H., Mukhopadhyay, D., Chen, R. L., Lander, A. D., Hagihara, K., Yamaguchi, Y., Sasisekharan, R., Cantley, L., and Sukhatme, V. P. Cell surface glypicans are low-affinity endostatin receptors. Mol. Cell, 7: 811-822, 2001.
38. Jenab. S., and Morris, P. L. Differential activation of signal transducer and activator of transcription (STAT)-3 and STAT-1 transcription factors and c-fos messenger ribonucleic acid by interleukin-6 and interferon γ in Sertoli cells. Endocrinology, 137: 4738-4743, 1996.
39. Tedjarati, S., Baker, C. H., Apte, S., Huang, S., Wolf, J. K., Killion, J. J., and Fidler, I. J. Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon a combined with paclitaxel. Clin. Cancer Res., 8: 2413-2422, 2002.
40. Inoue, K., Chikazawa, M., Fukata, S., Yoshikawa, C., and Shuin, T. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder. Clin Cancer Res., 8: 2389-2398, 2002.
41. Hirata, A., Ogawa, S., Kometani, T., Kuwano, T., Naito, S., Kuwano, M., and Ono, M. ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. Cancer Res., 62: 2554-2560, 2002.
42. Ellerhorst, J. A., Prieto, V. G., Ekmekcioglu, S., Broemeling, L., Yekell, S., Chada, S., and Grimm, E. A. Loss of MDA-7 expression with progression of melanoma. J. Clin. Oncol., 20: 1069-1074, 2002.
43. Chada, S., Nemunaitis, J., Tong, A., Zhang, Y., Su, D., Mhashilkar, A., Zou-Yang, H., Parker, K., Wilson, D., Merritt, J., and Coffee, K. Phase I dose-escalation study of Ad-mda7 (INGN 241) in patients with advanced carcinoma. Cancer Gene Ther., 8: S3, 2001.